Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.45 |
| ▸ | TUBB | P07437 | 1/20 | 0.45 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.45 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.45 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.45 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.45 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.45 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.45 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.45 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.45 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31461254 | 1.00 | HDAC3 (0.45) | HDAC3TUBB4ATUBBTUBA3CHDAC4 | |
| SCHEMBL182696 | 0.95 | SIGMAR1 (0.46) | HDAC3TUBB4ATUBBTUBA3CHDAC4 | |
| SCHEMBL31243457 | 0.95 | SIGMAR1 (0.46) | HDAC3TUBB4ATUBBTUBA3CHDAC4 | |
| SCHEMBL9106500 | 0.94 | SIGMAR1 (0.45) | HDAC3TUBB4ATUBBTUBA3CHDAC4 | |
| SCHEMBL9106576 | 0.84 | PIM1 (0.50) | HDAC3TUBB4ATUBBTUBA3CHDAC4 | |
| SCHEMBL9103613 | 0.84 | P2RX4 (0.46) | HDAC3TUBB4ATUBBTUBA3CHDAC4 | |
| SCHEMBL9106163 | 0.84 | P2RX4 (0.46) | HDAC3TUBB4ATUBBTUBA3CHDAC4 | |
| SCHEMBL9099180 | 0.84 | PIM1 (0.42) | HDAC3TUBB4ATUBBTUBA3CHDAC4 | |
| SCHEMBL9101900 | 0.84 | AHR (0.40) | HDAC3TUBB4ATUBBTUBA3CHDAC4 | |
| SCHEMBL9102744 | 0.84 | PIM1 (0.59) | HDAC3TUBB4ATUBBTUBA3CHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11573183-B2 | Chemiluminescent substrates for peroxidase with extended shelf-life | CYANAGEN S.R.L. (IT) | 2023-02-07 | — | — | US | claimed |
| EP-3855185-B1 | CHEMILUMINESCENT SUBSTRATES FOR PEROXIDASE WITH EXTENDED SHELF-LIFE | CYANAGEN SRL (IT) | 2022-07-06 | — | — | EP | claimed |
| US-20210231572-A1 | CHEMILUMINESCENT SUBSTRATES FOR PEROXIDASE WITH EXTENDED SHELF-LIFE | CYANAGEN S.R.L. (IT) | 2021-07-29 | — | — | US | claimed |
| EP-3855185-A1 | CHEMILUMINESCENT SUBSTRATES FOR PEROXIDASE WITH EXTENDED SHELF-LIFE | Cyanagen Srl (IT) | 2021-07-28 | — | — | EP | claimed |
| CN-113150775-A | Peroxidase chemiluminescent substrate with extended shelf life | 喜雅纳肯有限公司 | 2021-07-23 | — | — | CN | claimed |
| US-8012705-B2 | Nonseparation assay methods | BECKMAN COULTER, INC. (US) | 2011-09-06 | — | — | US | claimed |
| US-20110183361-A1 | Nonseparation Assay Methods | BECKMAN COULTER, INC. (US) | 2011-07-28 | — | — | US | claimed |
| US-RE49466-E1 | Solution phase homogeneous assays | BECKMAN COULTER, INC. (US) | 2023-03-21 | — | — | US | disclosed |
| US-11573183-B2 | Chemiluminescent substrates for peroxidase with extended shelf-life | CYANAGEN S.R.L. (IT) | 2023-02-07 | — | — | US | disclosed |
| EP-3855185-B1 | CHEMILUMINESCENT SUBSTRATES FOR PEROXIDASE WITH EXTENDED SHELF-LIFE | CYANAGEN SRL (IT) | 2022-07-06 | — | — | EP | disclosed |
| US-20210231572-A1 | CHEMILUMINESCENT SUBSTRATES FOR PEROXIDASE WITH EXTENDED SHELF-LIFE | CYANAGEN S.R.L. (IT) | 2021-07-29 | — | — | US | disclosed |
| EP-3855185-A1 | CHEMILUMINESCENT SUBSTRATES FOR PEROXIDASE WITH EXTENDED SHELF-LIFE | Cyanagen Srl (IT) | 2021-07-28 | — | — | EP | disclosed |
| CN-113150775-A | Peroxidase chemiluminescent substrate with extended shelf life | 喜雅纳肯有限公司 | 2021-07-23 | — | — | CN | disclosed |
| US-6858733-B2 | Compounds for generating chemiluminescence with a peroxidase | LUMIGEN, INC. (US) | 2005-02-22 | — | — | US | disclosed |
| EP-1456176-A4 | IMPROVED COMPOUNDS FOR GENERATING CHEMILUMINESCENCE WITH A PEROXIDASE | LUMIGEN INC (US) | 2004-11-03 | — | — | EP | disclosed |
| EP-1456176-A1 | IMPROVED COMPOUNDS FOR GENERATING CHEMILUMINESCENCE WITH A PEROXIDASE | LUMIGEN, INC. (US) | 2004-09-15 | — | — | EP | disclosed |
| US-20040176599-A1 | Compounds for generating chemiluminescence with a peroxidase | LUMIGEN, INC. | 2004-09-09 | — | — | US | disclosed |
| US-20030170762-A1 | Compounds for generating chemiluminescence with a peroxidase | LUMIGEN, INC. | 2003-09-11 | — | — | US | disclosed |
| US-20030170771-A1 | Compounds for generating chemiluminescence with a peroxidase | AKHAVAN-TAFTI HASHEM (US) | 2003-09-11 | — | — | US | disclosed |
| WO-2003053934-A1 | IMPROVED COMPOUNDS FOR GENERATING CHEMILUMINESCENCE WITH A PEROXIDASE | LUMIGEN, INC. (US) | 2003-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176599-A1 | Compounds for generating chemiluminescence with a peroxidase | LPO, MPO, GPX4 | HDAC3 4141/4885TUBB4A 2025/4885TUBB 2553/4885 |
| US-20030170762-A1 | Compounds for generating chemiluminescence with a peroxidase | LPO, MPO, GPX4 | HDAC3 4141/4885TUBB4A 2025/4885TUBB 2553/4885 |
| US-20030170771-A1 | Compounds for generating chemiluminescence with a peroxidase | LPO, MPO, GPX4 | HDAC3 4141/4885TUBB4A 2025/4885TUBB 2553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.